INCIDENCE OF MORTALITY AND APPROPRIATE SHOCKS IN PATIENTS WITH ISCHEMIC AND NON-ISCHEMIC CARDIOMYOPATHY AFTER RECEIVING IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

被引：0
|
作者：
Desai, H. [1 ]
Lai, H. [1 ]
Aronow, W. [1 ]
Amin, H. [1 ]
Gandhi, K. [1 ]
Frishman, W. [1 ]
Cohen, M. [1 ]
Sorbera, C. [1 ]
机构：
[1] New York Med Coll, Westchester Med Ctr, Valhalla, NY 10595 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2009年 / 57卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：618 / 618
页数：1
相关论文
共 50 条
  • [41] Clinical determinants of mortality in patients with angiographically proven ischemic and non-ischemic cardiomyopathy
    Bart, BA
    Shaw, LK
    McCants, CB
    Fortin, DF
    Lee, KL
    OConnor, CM
    CIRCULATION, 1996, 94 (08) : 1121 - 1121
  • [42] Cardiovascular Outcomes With Use of Primary Prevention Implantable Cardioverter Defibrillators in Patients With Non-Ischemic Cardiomyopathy: A Meta-Analysis and Meta-Regression Analysis
    Lone, Ahmad Naeem
    Ghosh, Priyanka
    Zaidi, Ali
    Sporn, Daniel
    Deshmukh, Pramod
    CIRCULATION, 2022, 146
  • [43] MRI Assessment of Myocardial Deformation for Risk Stratification of Major Arrhythmic Events in Patients with Non-Ischemic Cardiomyopathy Eligible for Primary Prevention Implantable Cardioverter Defibrillators
    Espe, Emil
    Stokke, Mathis Korseberg
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2024, 60 (05) : 1987 - 1988
  • [44] MRI Assessment of Myocardial Deformation for Risk Stratification of Major Arrhythmic Events in Patients With Non-Ischemic Cardiomyopathy Eligible for Primary Prevention Implantable Cardioverter Defibrillators
    Ghanbari, Fahime
    Cirillo, Julia
    Rodriguez, Jennifer
    Yue, Jennifer
    Morales, Manuel A.
    Kramer, Daniel B.
    Manning, Warren J.
    Nezafat, Reza
    Ngo, Long H.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2024, 60 (05) : 1976 - 1986
  • [45] Incidence of transthyretin cardiac amyloidosis in patients with non-ischemic cardiomyopathy
    Volodarsky, I.
    Fabrikant, J.
    Shimoni, S.
    Zilberman, L.
    Fuginferov, I.
    Tshori, S.
    Haberman, D.
    George, J.
    Livschitz, S.
    Goland, S.
    EUROPEAN HEART JOURNAL, 2018, 39 : 575 - 576
  • [46] Implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a meta-analysis of randomized controlled trials
    Masri, Ahmad
    Hammadah, Muhammad
    Adelstein, Evan
    Jain, Sandeep
    Saba, Samir
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2017, 7 (04) : 397 - +
  • [47] Prognostic biomarkers of mortality in patients with non-ischemic dilated cardiomyopathy
    Zasytyte, I.
    Vitkus, D.
    Zurauskas, E.
    Bironaite, D.
    Rucinskas, K.
    Celutkiene, J.
    Karciauskaite, D.
    Grabauskiene, V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 181 - 181
  • [48] Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study
    Nazer, Babak
    Dale, Zack
    Carrassa, Gianmarco
    Reza, Nosheen
    Ustunkaya, Tuna
    Papoutsidakis, Nikolaos
    Gray, Andrew
    Howell, Stacey J.
    Elman, Miriam R.
    Pieragnoli, Paolo
    Ricciardi, Giuseppe
    Jacoby, Daniel
    Frankel, David S.
    Owens, Anjali
    Olivotto, Iacopo
    Heitner, Stephen B.
    HEART RHYTHM, 2020, 17 (07) : 1107 - 1114
  • [49] The relation between digoxin and appropriate shocks in patients with ischemic heart failure and implantable cardioverter defibrillator
    Balci, K. Kevser
    Balci, M. K.
    Sen, F.
    Akboga, M. K.
    Maden, O.
    Selcuk, H.
    Selcuk, T.
    Balbay, Y.
    Temizhan, A.
    Aydogdu, S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 465 - 466
  • [50] Comparison of ventricular arrhythmia frequency in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy treated with implantable cardioverter defibrillators
    Ermis, C
    Zhu, AX
    Vanheel, L
    Lemke, MJ
    Sakaguchi, S
    Lurie, KG
    Lu, F
    Lin, J
    Benditt, DG
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (02): : 233 - 238
12345